What is Eporatio used for?

Eporatio is indicated for Anemia due to chemotherapy, Anemia of chronic renal failure.

What development phase is Eporatio in?

Eporatio is FDA-approved (marketed).

What is the generic name of Eporatio?

EPOETIN THETA is the generic (nonproprietary) name of Eporatio.

Last reviewed 2026-04-20 · How we verify

Eporatio (EPOETIN THETA)

FDA-approved approved Recombinant protein Quality 17/100

At a glance

Generic name	EPOETIN THETA
Target	Erythropoietin receptor
Modality	Recombinant protein
Therapeutic area	Hematology
Phase	FDA-approved
First approval	2009

Approved indications

Anemia due to chemotherapy
Anemia of chronic renal failure

Common side effects

No common side effects on file.

Key clinical trials

Erythropoietin to Improve Critical Care Patient Outcomes (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Eporatio CI brief — competitive landscape report
Eporatio updates RSS · CI watch RSS